TG Therapeutics
TGTX
52.95
+0.76
+1.46%
TG Therapeutics
US · TGTX
#1638 by market cap
Listed 1970
52.95
+0.76
+1.46%
Live - 5344 symbols - heartbeat 325s ago
· 2026-10-08 07:00
Pre-market
52.91
-0.08%
After-hours
53.18
+0.43%
- Market cap
- 8.11B
- P/E (TTM)i
- 19.32
- P/Bi
- 13.42
- EPSi
- 2.77
- Div yieldi
- 0.00%
- 52W posi
- 80%
Reader sentiment
Are you bullish or bearish on TGTX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 6 analysts
Buy
Avg price target
69.17 +30.6%
Price target rangecurrent 52.95
Low21.00
Avg69.17
High86.00
Buy 83%
Hold 0%
Sell 17%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-21 | H.C. Wainwright | -- | BUY | 78.00 |
| 2026-09-02 | B. Riley Securities | -- | BUY | 86.00 |
| 2026-09-01 | H.C. Wainwright | -- | BUY | 78.00 |
| 2026-08-10 | J.P. Morgan | -- | BUY | 72.00 |
| 2026-08-05 | BofA Securities | -- | SELL | 21.00 |
| 2026-08-04 | H.C. Wainwright | -- | BUY | 78.00 |
| 2026-08-03 | TD Cowen | -- | BUY | 75.00 |
| 2026-08-03 | H.C. Wainwright | -- | BUY | 78.00 |
| 2026-07-20 | TD Cowen | -- | BUY | 75.00 |
| 2026-07-16 | J.P. Morgan | -- | BUY | 65.00 |
| 2026-07-14 | Jefferies | -- | BUY | 83.00 |
| 2026-07-13 | H.C. Wainwright | -- | BUY | 77.00 |
| 2026-07-07 | BofA Securities | -- | SELL | 20.00 |
| 2026-07-06 | H.C. Wainwright | -- | BUY | 70.00 |
| 2026-06-21 | Jefferies | -- | BUY | 83.00 |
| 2026-06-09 | H.C. Wainwright | -- | BUY | 70.00 |
| 2026-06-04 | BofA Securities | -- | SELL | 17.00 |
| 2026-06-04 | H.C. Wainwright | -- | BUY | 70.00 |
| 2026-06-03 | Goldman Sachs | -- | HOLD | 41.00 |
| 2026-06-03 | H.C. Wainwright | -- | BUY | 70.00 |
| 2026-05-27 | Goldman Sachs | -- | HOLD | 41.00 |
| 2026-05-27 | H.C. Wainwright | -- | BUY | 70.00 |
| 2026-05-27 | J.P. Morgan | -- | BUY | -- |
| 2026-05-06 | TD Cowen | -- | BUY | 50.00 |
| 2026-05-06 | H.C. Wainwright | -- | BUY | 70.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-03 | -- | ±11.70% | -11.26% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±8.84% | +16.26% (beat) |
| 2025/Q4 | 2026-02-26 | -- | ±10.46% | +4.18% (in line) |
| 2025/Q3 | 2025-11-03 | -- | ±14.48% | -3.13% (in line) |
| 2025/Q2 | 2025-08-04 | -- | ±14.55% | -17.99% (beat) |
| 2025/Q1 | 2025-05-05 | -- | ±13.78% | -13.26% (in line) |
| 2024/Q4 | 2025-03-03 | -- | ±13.16% | +14.39% (beat) |
| 2024/Q3 | 2024-11-04 | -- | ±17.85% | -9.44% (in line) |
| 2024/Q2 | 2024-08-06 | -- | ±23.03% | +19.58% (in line) |
| 2024/Q1 | 2024-05-01 | -- | ±8.76% | +16.25% (beat) |
| 2023/Q4 | 2024-02-28 | -- | ±17.58% | +26.74% (beat) |
| 2023/Q3 | 2023-11-01 | -- | ±16.36% | +30.92% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:00:04 · For reference only, not investment advice and not tailored to your situation.